International Stem Cell (ISCO) EPS (Basic) (2010 - 2026)
International Stem Cell (ISCO) posted quarterly EPS (Basic) of -$0.03 for Q4 2025, down 1791.67% year-over-year from $0.0 in Q4 2024, and down 800.0% quarter-over-quarter from $0.0 in Q3 2025.
International Stem Cell (ISCO) EPS (Basic) (2010 - 2026) Analysis & Trends
International Stem Cell (ISCO) has reported EPS (Basic) for 16 consecutive years, with -$0.03 the latest figure, recorded in Q4 2025.
- In Q4 2025, EPS (Basic) fell 1791.67% year-over-year to -$0.03; the TTM figure through Dec 2025 stood at -$0.19 (down 394.92% YoY), while the FY2025 annual figure was -$0.99, down 3.76% from the prior year.
- EPS (Basic) declined to -$0.03 in Q4 2025 per ISCO's latest filing, from $0.0 in the prior quarter.
- Across five years, EPS (Basic) topped out at $0.02 in Q4 2022 and bottomed at -$0.12 in Q3 2021.
- Historically, EPS (Basic) has averaged -$0.03 across 5 years, with a median of -$0.02 in 2024.
- Annual changes were most pronounced in 2023 — EPS (Basic) surged 7230.58% — and 2025, when it plunged 1791.67%.
- International Stem Cell's EPS (Basic) stood at -$0.05 in 2021, then surged by 144.23% to $0.02 in 2022, then plunged by 303.12% to -$0.04 in 2023, then jumped by 103.69% to $0.0 in 2024, then slumped by 1791.67% to -$0.03 in 2025.
- Business Quant data shows ISCO's EPS (Basic) at -$0.03 in Q4 2025, $0.0 in Q3 2025, and -$0.06 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.23 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.06 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.18 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -0.72 |
| 10 | International Stem Cell | 4.32 Mn | 3.23 Mn | 1.46 Mn | -0.01 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.01 |
| Dec 31, 2025 | -0.03 |
| Sep 30, 2025 | 0.00 |
| Jun 30, 2025 | -0.06 |
| Mar 31, 2025 | -0.12 |
| Dec 31, 2024 | 0.00 |
| Sep 30, 2024 | -0.02 |
| Jun 30, 2024 | 0.01 |
| Mar 31, 2024 | -0.03 |
| Dec 31, 2023 | -0.04 |
| Sep 30, 2023 | -0.01 |
| Jun 30, 2023 | 0.02 |
| Mar 31, 2023 | 0.00 |
| Dec 31, 2022 | 0.02 |
| Sep 30, 2022 | -0.04 |
| Jun 30, 2022 | 0.00 |
| Mar 31, 2022 | 0.00 |
| Dec 31, 2021 | -0.05 |
| Sep 30, 2021 | -0.12 |
| Jun 30, 2021 | -0.12 |